Skip to main content
Premium Trial:

Request an Annual Quote

Diagnostic Hybrids Awarded US Patent

Premium
Diagnostic Hybrids has been awarded US Patent 7,341,829, “In situ growth, freezing and testing of cultured cells.”
 
The inventors listed on the patent are David Scholl, Francesco Ambesi-Impiombato, James Brown, Leonard Kohn, and Joseph Jollick, Jr.
 
According to its abstract, the patent provides methods for the in situ growth, freezing, and testing of cultured cells. Specifically, the patent describes methods for the long-term preservation of cells in ready-to-use formats for testing. The patent also provides rapid and easy-to-use methods to diagnose viral and other infections. In addition, the patent discusses easy-to-use methods to grow and store cells in situ for testing methods.

The Scan

Gone, But Now Reconstructed SARS-CoV-2 Genomes

In a preprint, a researcher describes his recovery of viral sequences that had been removed from a common database.

Rare Heart Inflammation Warning

The Food and Drug Administration is adding a warning about links between a rare inflammatory heart condition and two SARS-CoV-2 vaccines, Reuters reports.

Sandwich Sampling

The New York Times sent tuna sandwiches for PCR analysis.

Nature Papers Describe Gut Viruses, New Format for Storing Quantitative Genomic Data, More

In Nature this week: catalog of DNA viruses of the human gut microbiome, new dense depth data dump format to store quantitative genomic data, and more.